MedChina Insights

In July 2025, MedChina officially unveiled the 2025 Global MedTech 100 (GMT100), an authoritative annual ranking highlighting the world’s leading medical device companies based on their 2024 fiscal year revenue.

Chinese surgical robot maker Cornerstone Robotics is gaining global traction, with successful trials in the UK, partnerships in Singapore, and a cross-continent remote surgery demo, showcasing its ability to integrate into international healthcare systems.

As AI takes over imaging analysis, post-op care, and even treatment planning, this article explores how the role of ophthalmologists is being redefined, and what it means to be a “good doctor” in the age of algorithms.

Rossum Robot CEO Yu Wang shares how the company is advancing orthopedic surgical robotics in China through technological innovation, clinical validation, and a pragmatic path to commercialization.

Explore the future of surgical robotics at the Global Medical Robotics Conference 2025, where global leaders converge to drive innovation, commercialization, and international growth.

At the Global Orthopedics Conference 2025, MedChina explores how this rising Chinese medtech company is driving precision, adaptability, and openness to reshape the future of surgery — from China to the world.

Venus MedTech is redefining global heart valve innovation with China's first FDA-approved device. Discover how its strategic pivot and clinical breakthroughs are reshaping structural heart treatment worldwide.